跳至主要内容
临床试验/NCT00701051
NCT00701051已完成不适用

Aging, Angiogenesis and Metabolic Responses to Aerobic Exercise

US Department of Veterans Affairs2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2006年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
2
主要终点
Baseline Glucose Utilization

研究概览

简要总结

Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in older individuals with impaired glucose tolerance and we hypothesize that this is due to reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize that reversal of a sedentary lifestyle through aerobic exercise training will increase insulin signaling and vascular growth factor expression, as well as decrease inflammation, to increase capillary supply to skeletal muscle, which contributes to improved glucose metabolism in older adults. This study will: 1) Determine the mechanisms underlying reduced skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2) Determine the effect of aerobic exercise training-induced increases in skeletal muscle capillarization on glucose metabolism in older adults.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50-75 years
  • Non-smoker >2 years
  • Body mass index = 18-35 kg/m2

排除标准

  • History of CAD or cerebrovascular disease that would preclude exercise
  • Implantable defibrillator
  • Active cancer
  • Chronic pulmonary, thyroid, renal, liver, or hematological disease
  • HIV positive or prone to malnutrition
  • Sickle cell anemia
  • Type 1 diabetes, or currently on medication to treat type 2 diabetes
  • Poorly-controlled type 2 diabetes
  • Poorly-controlled hypertension
  • Taking medications including: beta-blockers, oral steroids, warfarin, certain statins, hormone replacement therapy (HRT), oral contraceptives (OCP), thiazolidinediones (TZD), or chronic steroids or nonsteroidal analgesics (NSAIDS) that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)
  • Allergic to lidocaine or heparin
  • Recent weight change (>5kg in 3 months)
  • Currently pregnant or nursing
  • Physical impairment limiting exercise
  • Dementia or unstable clinical depression

结局指标

主要结局

Baseline Glucose Utilization

时间窗: baseline

Insulin-stimulated glucose uptake

Glucose Utilization (Pre/Post Intervention)

时间窗: baseline, 24 weeks, 26 weeks

Insulin-stimulated glucose uptake

Baseline Skeletal Muscle Capillarization

时间窗: baseline

Skeletal Muscle Capillarization (Pre/Post Intervention)

时间窗: baseline, 24 weeks, 26 weeks

次要结局

  • Baseline 2-hour Postprandial Glucose(baseline)
  • Baseline Cardiorespiratory Fitness(baseline)
  • Cardiorespiratory Fitness(baseline, 24 weeks, 26 weeks)
  • Body Composition (%Fat)(baseline, 24 weeks)
  • 2-hr Post-prandial Plasma Glucose Level(baseline, 24 weeks, 26 weeks)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验